Immunogenicity and Reactogenicity of PCV13 Among Infants and Children in Burkina Faso

NCT01577771 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

663

Enrollment

OTHER

Sponsor class

Conditions

Pneumococcal Infections

Interventions

BIOLOGICAL: Prevnar13 (manufactured by Pfizer)

Sponsor

Agence de Médecine Préventive, France